Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David M. Goldstein currently holds 30,970 shares of Principia Biopharma Inc. (PRNB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David M. Goldstein has been a net seller of PRNB stock. They have purchased $0 and sold $961.0K worth of shares.
David M. Goldstein's most recent insider trade was on Aug 3, 2026, when they sold 2,596 shares at $26.37 per share.
David M. Goldstein serves as Executive at Principia Biopharma Inc. (PRNB). They have executed 27 insider transactions totaling $961.0K over their tenure at the company.
David M. Goldstein holds the position of Executive at Principia Biopharma Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
David M. Goldstein has shown a selling trading pattern, with $0 in total purchases and $961.0K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by David M. Goldstein was on Sep 28, 2020, when they sold $3.2M worth of PRNB shares. This transaction involved 31,826 shares at $100.00 per share.
David M. Goldstein currently owns 30,970 shares of Principia Biopharma Inc. (PRNB), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David M. Goldstein's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David M. Goldstein has 27 Form 4 filings on record as an insider at Principia Biopharma Inc..
Set alerts for David M. Goldstein and 40,000+ other insiders.